Prana raises US$3.7 million

By Staff writer
Wednesday, 08 December, 2004

A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.

The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.

The exercise of options increases the total issued shares in Prana to 126,890,821.

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...

Content from other channels on our network

Larry Emdur's whisky brand appoints CEO

Fonterra's leadership changes confirmed

Driving food safety through digital traceability and transparency

Mars expands local pet food production with new $112.6m facility now open

New analytical method for testing gluten-free beer assessed

Australian health care's burnout prescription

"Fake podiatrist" jailed after hundreds of consultations with vulnerable patients

Unlocking the potential of our nursing workforce

National Model for Clinical Governance now available

SEKO IoT solutions revolutionise on-premise laundry dosing

From Dark Age to Imperial: what Age of Empires teaches us about instrumentation

WA Government to boost development of Collie green steel mill

Queensland increases investment in CopperString

Demystifying zero trust in OT

LION to close James Boag's Brewery in Launceston